Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Psychiatr Serv. 2020 Dec 9;72(7):812–821. doi: 10.1176/appi.ps.202000003

Table 3:

Study Outcomes

Definition Type
Primary Outcome
Fidelity in depression screening Probability that each patient eligible for depression screening completes depression screening. Binary
Fidelity in depression treatment initiation Probability that each patient eligible for depression treatment actually starts treatment within 30 days of identification.* Binary
Fidelity in follow-up depression treatment monitoring and adjustment Probability at each follow-up appointment in the first three months of depression treatment that the clinical treatment decision follows the depression treatment guidelines. Binary
Secondary Outcomes
Probability that each patient achieves depression remission at 3 months. Depression remission is defined as a Patient Health Questionnaire-9 score <5 at 3 months Binary
Probability that each NCD patient’s NCD is well controlled at 3 months.** Well-controlled NCD will be defined for hypertension patients as systolic blood pressure <140 mmHg AND diastolic blood pressure <90 mmHg, and for diabetes patients as fasting blood glucose <130 mg/dl, following the Malawi Clinical Guidelines for the Management of NCDs Binary
*

Eligibility for depression treatment is defined as having a PHQ-9 total score of 5 or above and having a final determination from the treating clinician that the patient is appropriate for depression treatment.

**

Hypertension is measured by research assistants at each study visit while fasting blood glucose is measured as part of routine clinical care and will be abstracted.